TCTR20201104003招募中2 期
The study of clinical effectiveness and safety of a combination of 0.4% minoxidil and 0.05% retinaldehyde nanoparticles solution for treatment of androgenetic alopecia
ermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital0 个研究点目标入组 30 人开始时间: 2020年11月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1.Patient with androgenetic alopecia with Norwood-Hamilton grade 3-4 or Ludwig
- •2.Volunteers who have well adherence and can be followed up as appointed grade 1-2
排除标准
- •1.Prior treatment of androgenetic alopecia with topical therapy within 3 months
- •2.Prior treatment of androgenetic alopecia with oral therapy within 6 months
- •3.Prior treatment of androgenetic alopecia with hair transplantation within 12 months
- •4.Pregnancy or breastfeeding
- •5.Hirsutism
- •6.Abnormal thyroid function
- •7.Iron deficiency anemia
- •8.Patient recieved contraception or hormone replacement therapy
研究者
相似试验
已完成
不适用
A clinical study of the Safety and effectiveness of Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) treatment for the palliation of painful bone metastasesJPRN-UMIN000012441Department of Orthopaedic Surgery, Kochi Medical School, Kochi University25
尚未招募
4 期
Clinical Study on the Effectiveness and Safety of Guanxinning Tablets on Coronary Heart Disease Complicated with Diabetic NephropathyITMCTR2100005416Affiliated Hospital of Hangzhou Normal University
已完成
不适用
Investigation for clinical efficacy and safety of ipragliflozin 50mg and 100mg on type 2 diabetesType 2 diabetesJPRN-UMIN000016131Osaka Saiseikai Nakatsu Hospital Division of diabetes and endocrinology600
招募中
3 期
A clinical study to evaluate the efficacy and safety of the Vamana karma followed with two Rasayanas Takradhara and Rasaoushadi in treatment of psoriasis.CTRI/2016/02/006631Central council for Research in Ayurvedic sciences CCRAS110
已完成
不适用
Evaulation of the clinical efficacy and safety of the combined administration of Imidafenacin and Tamsulosin in BPH patients (in which OAB symptoms remain) who did not respond to alpha-1 blocker monotherapy.Overactive bladderJPRN-UMIN000005012Department of Urology, University of Yamanashi, School of Medicine300